• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

法国一家大学医院控制产OXA-48碳青霉烯酶肺炎克雷伯菌大规模暴发的挑战。

Challenges of controlling a large outbreak of OXA-48 carbapenemase-producing Klebsiella pneumoniae in a French university hospital.

作者信息

Semin-Pelletier B, Cazet L, Bourigault C, Juvin M E, Boutoille D, Raffi F, Hourmant M, Blancho G, Agard C, Connault J, Corvec S, Caillon J, Batard E, Lepelletier D

机构信息

Bacteriology and Hygiene Department, Nantes University Hospital, Nantes, France.

Infectious Diseases Department, Nantes University Hospital, Nantes, France; University of Nantes, EA 3826, UFR Medicine School, Nantes, France.

出版信息

J Hosp Infect. 2015 Apr;89(4):248-53. doi: 10.1016/j.jhin.2014.11.018. Epub 2015 Jan 5.

DOI:10.1016/j.jhin.2014.11.018
PMID:25601745
Abstract

A large outbreak of OXA-48 carbapenemase-producing Klebsiella pneumoniae at Nantes University Hospital was investigated. The index case had no history of travel or hospitalization abroad and had been hospitalized in the internal medicine department for more than one month when the epidemic strain was isolated from a urine sample in June 2013. Seventy-two secondary cases were detected by weekly screening for gastrointestinal colonization during the two phases of the outbreak from June to October 2013 (33 cases) and from November 2013 to August 2014 (39 cases). Spread of the epidemic strain was attributed to the proximity of, and staff movement between, the infectious diseases (32 cases) and the internal medicine (26 cases) departments; 14 secondary cases were also observed in the renal transplant department following the transfer of an exposed patient from the infectious diseases department. Most of the patients (90%) were colonized and no death was linked to the epidemic strain. More than 3000 contact patients were reviewed and 6000 rectal swabs were performed. Initial control measures failed to control the outbreak owing to the late detection of the index case. The late implementation of three successive cohort units, the large number of transfers between wards, and the frequent readmission of cases contributed to the incomplete success of control measures.

摘要

对南特大学医院发生的一起由产OXA - 48碳青霉烯酶肺炎克雷伯菌引起的大规模疫情进行了调查。首例病例无国外旅行或住院史,2013年6月从其尿液样本中分离出流行菌株时,该病例已在内科住院一个多月。在2013年6月至10月(33例)和2013年11月至2014年8月(39例)这两个疫情阶段,通过每周对胃肠道定植情况进行筛查,共检测到72例二代病例。流行菌株的传播归因于传染病科(32例)和内科(26例)相邻以及工作人员在两科室之间流动;一名暴露患者从传染病科转入肾移植科后,该科室也观察到14例二代病例。大多数患者(90%)被定植,且无死亡与流行菌株相关。对3000多名接触患者进行了检查,并采集了6000份直肠拭子样本。由于首例病例发现较晚,最初的控制措施未能控制住疫情。三个连续队列单元实施较晚、病房之间大量的患者转运以及病例频繁再次入院,导致控制措施未完全成功。

相似文献

1
Challenges of controlling a large outbreak of OXA-48 carbapenemase-producing Klebsiella pneumoniae in a French university hospital.法国一家大学医院控制产OXA-48碳青霉烯酶肺炎克雷伯菌大规模暴发的挑战。
J Hosp Infect. 2015 Apr;89(4):248-53. doi: 10.1016/j.jhin.2014.11.018. Epub 2015 Jan 5.
2
Successful control of the first OXA-48 and/or NDM carbapenemase-producing Klebsiella pneumoniae outbreak in Slovenia 2014-2016.2014-2016 年斯洛文尼亚成功控制首例 OXA-48 和/或 NDM 碳青霉烯酶产生的肺炎克雷伯菌爆发
J Hosp Infect. 2019 Feb;101(2):142-149. doi: 10.1016/j.jhin.2018.10.022. Epub 2018 Nov 3.
3
Prolonged delay for controlling KPC-2-producing Klebsiella pneumoniae outbreak: the role of clinical management.控制产KPC-2肺炎克雷伯菌暴发的长期延误:临床管理的作用
Am J Infect Control. 2015 Oct 1;43(10):1070-5. doi: 10.1016/j.ajic.2015.05.021. Epub 2015 Jul 11.
4
Persisting transmission of carbapenemase-producing Klebsiella pneumoniae due to an environmental reservoir in a university hospital, France, 2012 to 2014.2012 年至 2014 年期间,由于环境储库的存在,法国某大学医院中碳青霉烯酶产生肺炎克雷伯菌持续传播。
Euro Surveill. 2016 Apr 28;21(17). doi: 10.2807/1560-7917.ES.2016.21.17.30213.
5
Interhospital spread of NDM-7-producing Klebsiella pneumoniae belonging to ST437 in Spain.西班牙产 NDM-7 的肺炎克雷伯菌 ST437 属的医院间传播
Int J Antimicrob Agents. 2015 Aug;46(2):169-73. doi: 10.1016/j.ijantimicag.2015.04.001. Epub 2015 Apr 30.
6
Intensive care unit outbreak of extended-spectrum beta-lactamase-producing Klebsiella pneumoniae controlled by cohorting patients and reinforcing infection control measures.通过对患者进行分组并加强感染控制措施,重症监护病房产超广谱β-内酰胺酶肺炎克雷伯菌的暴发得到了控制。
Infect Control Hosp Epidemiol. 2008 Jun;29(6):517-24. doi: 10.1086/588004.
7
Emergence and rapid regional spread of Klebsiella pneumoniae carbapenemase-producing Enterobacteriaceae.产碳青霉烯酶肠杆菌科细菌的出现和快速区域性传播。
Clin Infect Dis. 2011 Sep;53(6):532-40. doi: 10.1093/cid/cir482.
8
Outbreak of colonization by carbapenemase-producing Klebsiella pneumoniae in a neonatal intensive care unit: Investigation, control measures and assessment.新生儿重症监护病房产碳青霉烯酶肺炎克雷伯菌定植暴发:调查、控制措施及评估
Am J Infect Control. 2015 Oct 1;43(10):1122-4. doi: 10.1016/j.ajic.2015.05.038. Epub 2015 Jul 3.
9
Investigation of the first outbreak of OXA-48-producing Klebsiella pneumoniae in Ireland.爱尔兰首次暴发产 OXA-48 型肺炎克雷伯菌疫情调查。
J Hosp Infect. 2014 May;87(1):41-6. doi: 10.1016/j.jhin.2014.03.001. Epub 2014 Mar 25.
10
Outbreak of NDM-1+CTX-M-15+DHA-1-producing Klebsiella pneumoniae high-risk clone in Spain owing to an undetectable colonised patient from Pakistan.西班牙爆发携带 NDM-1+CTX-M-15+DHA-1 基因的高产 DHA 型肺炎克雷伯菌,源于一位来自巴基斯坦的无症状定植感染者。
Int J Antimicrob Agents. 2019 Aug;54(2):233-239. doi: 10.1016/j.ijantimicag.2019.05.021. Epub 2019 Jun 4.

引用本文的文献

1
Global Threat of Carbapenem-Resistant Gram-Negative Bacteria.全球碳青霉烯类耐药革兰氏阴性菌的威胁
Front Cell Infect Microbiol. 2022 Mar 15;12:823684. doi: 10.3389/fcimb.2022.823684. eCollection 2022.
2
Simultaneous Hospital Outbreaks of New Delhi Metallo-β-Lactamase-Producing Unraveled Using Whole-Genome Sequencing.应用全基因组测序技术揭示新德里金属β-内酰胺酶产生菌的医院同期暴发
Microbiol Spectr. 2022 Apr 27;10(2):e0228721. doi: 10.1128/spectrum.02287-21. Epub 2022 Mar 21.
3
Prophylaxis and Treatment against : Current Insights on This Emerging Anti-Microbial Resistant Global Threat.
预防和治疗:对抗这种新兴的抗微生物耐药性全球威胁的最新见解。
Int J Mol Sci. 2021 Apr 14;22(8):4042. doi: 10.3390/ijms22084042.
4
The Global Ascendency of OXA-48-Type Carbapenemases.OXA-48 型碳青霉烯酶的全球优势地位
Clin Microbiol Rev. 2019 Nov 13;33(1). doi: 10.1128/CMR.00102-19. Print 2019 Dec 18.
5
Treatment of Infections by OXA-48-Producing Enterobacteriaceae.产 OXA-48 肠杆菌科细菌感染的治疗。
Antimicrob Agents Chemother. 2018 Oct 24;62(11). doi: 10.1128/AAC.01195-18. Print 2018 Nov.
6
Diversity of Carbapenemase-Producing Escherichia coli Isolates in France in 2012-2013.2012-2013 年法国产碳青霉烯酶大肠埃希菌分离株的多样性。
Antimicrob Agents Chemother. 2018 Jul 27;62(8). doi: 10.1128/AAC.00266-18. Print 2018 Aug.
7
A Systematic Review and Meta-analyses of the Clinical Epidemiology of Carbapenem-Resistant Enterobacteriaceae.碳青霉烯类耐药肠杆菌科的临床流行病学系统评价和荟萃分析。
Antimicrob Agents Chemother. 2017 Dec 21;62(1). doi: 10.1128/AAC.01730-17. Print 2018 Jan.
8
Trends in carbapenemase-producing Enterobacteriaceae, France, 2012 to 2014.2012年至2014年法国产碳青霉烯酶肠杆菌科细菌的流行趋势
Euro Surveill. 2017 Feb 9;22(6). doi: 10.2807/1560-7917.ES.2017.22.6.30461.
9
Global Dissemination of Carbapenemase-Producing Klebsiella pneumoniae: Epidemiology, Genetic Context, Treatment Options, and Detection Methods.产碳青霉烯酶肺炎克雷伯菌的全球传播:流行病学、基因背景、治疗选择及检测方法
Front Microbiol. 2016 Jun 13;7:895. doi: 10.3389/fmicb.2016.00895. eCollection 2016.